Showing 3811-3820 of 21443 results for "".
- Progress in Treating High Cholesterol: Clinical Trial Interim Resultshttps://reachmd.com/news/progress-in-treating-high-cholesterol-clinical-trial-interim-results/2456895/High cholesterol can cause plaque buildup in the arteries. Over time, this can lead to heart attack. ... [+] One clinical trial aims to lower LDL cholesterol for a lifetime with a single infusion of gene-editing RNA.getty<
- UVA Researchers ID Novel Factor in HIV Transmissionhttps://reachmd.com/news/uva-researchers-id-novel-factor-in-hiv-transmission/2456901/Now UVA researchers have identified what they believe is a previously unknown, but critical factor. Successful transmission, they believe, is influenced by a protein the virus makes and how that protein interacts with the RNA of the virus. Natural variation in this
- ‘Bad Idea’: Warning Over Cosmetic Procedure to Change Eye Color Going Viralhttps://reachmd.com/news/bad-idea-warning-over-cosmetic-procedure-to-change-eye-color-going-viral/2456893/Experts have warned against an iris colour-changing procedure going viral on social media, saying it can result in blindness. The process, known as keratopigmentation, involves using a laser to create a tunnel in the superficial cornea in order to place pigment, the
- Researchers Identify Key Characteristics Associated with Improved CAR T Outcomes in Large B Cell Lymphomahttps://reachmd.com/news/researchers-identify-key-characteristics-associated-with-improved-car-t-outcomes-in-large-b-cell-lymphoma/2456904/TAMPA, Fla. — Chimeric antigen receptor T-cell therapy, or CAR T, has dramatically improved the treatment of certain blood cancers. Initially approved for
- Innovative COVID-19 Analysis Supports Prevention Protocols in Health Care Settingshttps://reachmd.com/news/innovative-covid-19-analysis-supports-prevention-protocols-in-health-care-settings/2456885/In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious and pathogenic virus, made its alarming debut and quickly spread worldwide, causing the novel coronavirus (COVID-19) pandemic that threatened human health and publi
- SARS-CoV-2 Can Infect Dopamine Neurons Causing Senescencehttps://reachmd.com/news/sars-cov-2-can-infect-dopamine-neurons-causing-senescence/2456886/A new study reported that SARS-CoV-2, the virus that causes COVID, can infect dopamine neurons in the brain and trigger senescence—when a cell loses the ability to grow and divide. The researchers from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Columbi
- Researchers Identify Key Characteristics Associated with Improved CAR T Outcomes in Large B Cell Lymphomahttps://reachmd.com/news/researchers-identify-key-characteristics-associated-with-improved-car-t-outcomes-in-large-b-cell-lymphoma/2456906/Newswise — TAMPA, Fla. — Chimeric antigen receptor T-cell therapy, or CAR T, has dramatically improved the treatment of certain blood cancers. Initially approved for pat
- University of North Carolina Study Finds Infliximab Biosimilars Comparable to Remicade in Gastroenterology and Rheumatology Clinicshttps://reachmd.com/news/university-of-north-carolina-study-finds-infliximab-biosimilars-comparable-to-remicade-in-gastroenterology-and-rheumatology-clinics/2456872/© MQ-Illustrations - stock.adobe.comRemicade (infliximab), marketed by Janssen Biotech, is a tumor necrosis factor inhibitor approved by the FDA in 1998 for managing Crohn’s disease. Since then, the biologic has received approval for se
- Insufficient Disease Control in Severe AD: Year-long Longitudinal Study Reveals Treatment Gapshttps://reachmd.com/news/insufficient-disease-control-in-severe-ad-year-long-longitudinal-study-reveals-treatment-gaps/2456864/A recent study presented at the Revolutionizing Atopic Dermatitis (RAD) Virtual Conference highlighted has shed light on the persistent issue of therapeutic inertia in the treatment of moderate-to-severe atopic dermatitis (AD), even wit
- Insufficient Disease Control in Moderate-to-Severe AD: Year-long Longitudinal Study Reveals Treatment Gapshttps://reachmd.com/news/insufficient-disease-control-in-severe-atopic-dermatitis-a-12-month-longitudinal-study-reveals-treatment-gaps/2462212/A recent study presented at the Revolutionizing Atopic Dermatitis (RAD) Virtual Conference highlighted has shed light on the persistent issue of therapeuti